Navigation Links
Roche Diagnostics Supports Fight Against MRSA as a Sponsor of Annual World MRSA Day on October 1
Date:9/28/2011

INDIANAPOLIS, Sept. 28, 2011 /PRNewswire/ -- As part of its ongoing work in the prevention and control of serious infections in healthcare settings, Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today its sponsorship of the 3rd Annual World MRSA Day. The kick-off event and global MRSA summit will be held on October 1, 2011, at Loyola University Stritch School of Medicine in Maywood, Ill.

Organized by the MRSA Survivors Network, World MRSA Day highlights the importance of a comprehensive approach to controlling MRSA (methicillin-resistant Staphylococcus aureus), a type of bacterium that is resistant to common antibiotics and can cause serious infections. High rates of infection and mortality and high costs of treatment due to healthcare-associated infections (HAIs) caused by MRSA are a critical issue for healthcare facilities worldwide. The goal for the event is to raise widespread awareness of the need for greater MRSA prevention, screening, treatment and education.

"Roche applauds the MRSA Survivors Network for bringing this important issue to the forefront and we are honored to be a sponsor of World MRSA Day," said Jack Phillips, president and CEO of Roche Diagnostics Corporation. "Healthcare-associated infections caused by MRSA are preventable, and we believe that more education, together with effective screening and infection control programs, can significantly reduce the spread of MRSA and its consequences."

The kick-off event, which features MRSA expert and former CDC scientist William R. Jarvis, M.D., as keynote speaker, will be broadcast live via web stream starting at 10:30 a.m. central time on Oct. 1 and can be viewed at www.worldmrsaday.org and www.MRSAsurvivors.org.

About HAIs and MRSA screening

Healthcare-associated infections (HAIs) caused by MRSA are a tremendous burden for healthcare systems and hospitals and are associated with significant healthcare costs. The Centers for Disease Control and Prevention (CDC) has estimated that approximately 18,000 persons die of invasive MRSA HAIs in U.S. healthcare facilities annually – more than from HIV/AIDS – underscoring the need for comprehensive infection control programs, along with more rapid and reliable MRSA screening methods. In response to this public health issue, an increasing number of states have passed legislation requiring mandatory reporting and/or screening for HAIs.  

About Roche

Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world's largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche's personalized healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients. In 2010, Roche had over 80,000 employees worldwide and invested over 9 billion Swiss francs in R&D. The Group posted sales of 47.5 billion Swiss francs. Genentech, United States, is a wholly owned member of the Roche Group. Roche has a majority stake in Chugai Pharmaceutical, Japan. For more information: www.roche.com or www.roche-diagnostics.us.

All trademarks used or mentioned in this release are protected by law.

For further information, please contact:
Betsy Cox
Director, Corporate Communications
Roche Diagnostics Corporation
Indianapolis, IN
(317) 521-3911
betsy.cox@roche.com


'/>"/>
SOURCE Roche Diagnostics
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Pfizer Overtakes GSK but Trails Roche in PharmaDeals Corp-METRx Analysis of Deal Activity
2. Roche Starts Early Stage Clinical Trial in Down Syndrome
3. Roche Diabetes Care Celebrates Second Annual Infusion Site Awareness Week, Aug. 29-Sept. 4
4. Rochester Medical Reports Fiscal 2011 Third Quarter Results
5. Rochester Medical Announces Third Quarter 2011 Earnings Conference Call Thursday, July 28, 2011
6. Roche NimbleGen and Caliper Collaborate to Offer Automated Target Enrichment Pipeline Solution for Next-Generation Sequencing
7. In Support of the International Day of the African Child, Roche Hosts Annual Childrens Walk
8. Deadly E. Coli Strain Sequenced With Roche GS Junior System by HPA Scientists - Provides Community Most Complete Assembly to Date
9. Roche and Clovis Oncology to Co-Develop EGFR Companion Diagnostic
10. Florida Hospital First U.S. Site to Adopt New Automated Laboratory Solution From Roche
11. Roche Symposium Showcases Accomplishments of Next Generation of Chemists
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Mass. and SAN CLEMENTE, Calif. , ... California -based mobile pulmonary function testing company, is now able ... PFT devices developed by ndd Medical Technologies , Inc. ... testing done in hospital-based labs.  Thanks to ndd,s EasyOne PRO ® ... , can get any needed testing done in the comfort ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, a ... invasive and more durable cerebrospinal fluid treatments, today ... The Series-A funding is led by Innova Memphis, ... and other private investors.  Arkis, new financing will ... and the market release of its in-licensed Endexo® ...
(Date:6/23/2016)... startling report released today, National Safety Council research shows ... plan to eliminate prescription opioid overdoses. Prescription Nation ... the worst drug crisis in recorded U.S. history, assigned a "Making ... , New Mexico , Tennessee ... states, three – Michigan , Missouri ...
Breaking Medicine Technology:
(Date:6/25/2016)... , ... June 25, 2016 , ... Austin residents seeking ... American College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical ... effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... As a ... Magna Cum Laude and his M.D from the David Geffen School of Medicine at ... returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars ...
(Date:6/24/2016)... Los Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... plastic surgery procedures that most people are unfamiliar with. The article goes on to ... known procedures, but also many of these less common operations such as calf and ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Scientific Sessions in Dallas that it will receive two significant new grants to ... came as PHA marked its 25th anniversary by recognizing patients, medical professionals and ...
(Date:6/24/2016)... Rhinebeck, NY (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of ... of companies that call for a minimum wage raise to $12 an hour by 2020 ... wage. This will restore the lost value of the minimum wage, assure the wage floor ...
Breaking Medicine News(10 mins):